The India prefilled syringes market was valued at USD 324.91 Million in 2025 and is expected to grow at a CAGR of 9.20%, reaching USD 783.41 Million by 2035. The market is driven by increasing demand for convenient drug delivery systems and the growing prevalence of chronic diseases requiring injectable treatments. Rising adoption of self-injection devices, coupled with technological advancements enhancing product safety and usability, is expected to support market expansion. The emergence of biologics and biosimilars further fuels market growth over the forecast period.
Base Year
Historical Period
Forecast Period
According to the Indian Council of Medical Research (ICMR), over 14 lakh cancer cases were reported in India in 2023, significantly fueling the growth of the prefilled syringes market due to rising demand for injectable treatments.
Rising demand for efficient drug delivery and advancements in biologics are key factors significantly driving the growth of the India prefilled syringes market.
The market growth is positively impacted by strategic initiatives, product innovations, and expansions undertaken by leading pharmaceutical and medical device companies operating in the prefilled syringes.
Compound Annual Growth Rate
9.2%
Value in USD Million
2026-2035
*this image is indicative*
Prefilled syringes have gained significant traction in modern drug delivery systems due to their convenience, accuracy, and reduced risk of contamination. Their growing adoption across therapeutic areas reflects the healthcare industry’s shift toward user-friendly and cost-effective solutions. The market is experiencing robust growth, driven by the rising prevalence of chronic diseases, increasing demand for self-administration, and expanding healthcare infrastructure. Technological advancements and favorable government initiatives further support market expansion. The market was valued at USD 324.91 Million in 2025, with strong prospects for sustained growth as pharmaceutical companies invest in safer, more efficient injectable drug delivery formats.
Rising Focus on Advanced Injectable Drug Delivery to Boost the Growth in the Market
The growing emphasis on peptide-based therapeutics and advanced injectable formulations is accelerating the demand for prefilled syringes in India. This trend is supported by increasing pharmaceutical innovation aimed at enhancing patient convenience and dosing accuracy. For example, in February 2024, Lupin, an Indian company, launched Ganirelix Acetate Injection in a single-dose prefilled syringe format in the United States, its first peptide-based injectable, demonstrating the industry’s shift toward ready-to-administer drug delivery systems. Such developments by Indian companies are expected to boost domestic capabilities and adoption, thereby driving steady growth in the India prefilled syringes market.
Some of the trends in the market include the growing emphasis on securing USFDA approvals and the increasing prevalence of rheumatoid arthritis, both contributing to the rising adoption of prefilled syringes.
Rising FDA Approvals for Prefilled Syringes to Enhance the Market Value
The market is witnessing a growing trend of domestic pharmaceutical companies securing regulatory approvals for advanced injectable therapies, particularly targeting global markets. In June 2024, Alembic Pharmaceuticals received final approval from the US Food and Drug Administration for its Icatibant Injection in a single-dose prefilled syringe format. This approval marked the company’s first peptide product clearance, signifying India’s strengthening capabilities in complex injectables. This trend is expected to drive innovation and boost market growth in the prefilled syringes segment.
Increasing Prevalence of Rheumatoid Arthritis to Boost India Prefilled Syringes Market Demand
The growing burden of chronic autoimmune conditions is driving the adoption of advanced drug delivery systems in India. A significant rise in rheumatoid arthritis (RA) cases is contributing to this trend. Chandrashekara S et al. 2024, reported that RA affects approximately 5-7 million individuals in India, with a national prevalence of 0.75%. This escalating disease burden is expected to increase the demand for convenient, self-administered treatment options, thereby strengthening the growth of the market.
Diabetes to Lead the Market Share by Application
The market comprises a wide range of applications, including diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis, ophthalmology, and others. Among these, diabetes is expected to emerge as the leading segment, primarily due to the growing patient population requiring regular insulin administration. According to the International Diabetes Federation (IDF), India currently has around 77 million individuals aged 20 to 79 living with diabetes, with the number forecasted to reach 134.2 million by 2045. The increasing demand for convenient and safe delivery methods, such as prefilled syringes, to manage chronic conditions like diabetes is anticipated to significantly boost market growth in this segment.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Becton Dickinson (BD) is a leading global medical technology company and a key player in India’s prefilled syringes market. In India, BD markets its BD PosiFlush™ prefilled saline syringe, designed to streamline vascular access device flushing while reducing contamination risk through its sterile design. The company is also recognized among the key players actively driving growth in the Indian prefilled syringes sector
Gerresheimer AG is a prominent packaging and delivery systems specialist, ranking among the key players in India’s prefilled syringes market. Globally, it offers a comprehensive portfolio including prefillable syringes, both glass and polymer types, and produces advanced ready-to-fill (RTF) glass syringes in nested formats such as the Gx RTF® series underscoring its technological strength and influence in the prefilled syringes domain.
Schott AG, through its Indian arm SCHOTT Poonawalla (a joint venture with Serum Institute of India), is a leading provider of injectable-focused primary packaging, including prefilled syringes, vials, ampoules, and cartridges—serving over 100 pharma customers from three manufacturing facilities capable of over 3 billion units annually. Additionally, SCHOTT has launched a highly customizable glass prefillable syringe portfolio in India, like the syriQ BioPure®, offering stability for sensitive drugs. In August 2025, it became the first company in India to locally manufacture high-precision glass tubing for syringes and cartridges, bolstering local supply capabilities for biologics and prefilled systems.
Terumo Corporation, via Terumo India, is active in the country’s broader drug delivery landscape, offering prefilled drug-device combination products. The company’s Pharmaceutical Solutions Division supports pharma companies from clinical trial manufacture to commercialization, providing innovations like ready-to-fill syringes, auto-injector compatible prefilled devices, and safety-enabled drug kits. In the Indian context, while its focus is broader than just prefilled syringes, Terumo supports customized, safe drug delivery platforms designed for Indian healthcare needs.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Nipro Corporation, AptarGroup, Inc., Catalent, Inc., Stevanato Group and Weigao Medical International Co., Ltd., among others.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Material
Market Breakup by Design
Market Breakup by Application
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Material |
|
| Breakup by Design |
|
| Breakup by Application |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share